Skin Ulcer denials in California external review
In the California DMHC record, independent physician reviewers decided 16 published external-review cases involving skin ulcerand overturned the plan’s denial in 25%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Most-fought treatments for skin ulcer
| Category | Decisions | Overturned |
|---|---|---|
| Inpt Admission | 4 | 25% |
| Hyperbaric O2 Chamb | 3 | 33.3% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 10 | 20% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 6 | 33.3% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for skilled nursing facility (SNF) level of care. Findings: As noted in the medical literature, SNF admission may be indicated for patients with more than one wound, including a stage 3 pressure ulcer, rehabilitation, gait training, and observation. One study noted that, “Pressure ulcers (PUs) are injuries to the skin and underlying tissues that occur most commonly over bony prominences, such as the hips and heels as a result of pressure and shear forces.” Another study analyzed 477 patient records to determine the percentage of patients with pressure ulcers/injuries (PU/Is) who required admission to a SNF for wound care. The authors found that the majority of patients with a PU/I required admission from home to a SNF for appropriate care.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for additional hyperbaric oxygen therapy (HBOT) treatment. Although there are limited data from prospective randomized controlled clinical trials demonstrating improved health outcomes with HBOT in this patient’s clinical setting, there are data suggesting that HBOT may be beneficial. One study evaluated patients with nonhealing chronic wounds who were treated with HBOT. The authors found that “A majority of the patients in our study referred with nonhealing wounds clinically improved when adjuvant HBOT was added to standard wound care protocols.” Moreover, this patient’s records document clinical improvement with the first HBOT 20 treatment sessions.
Where the denial was upheld
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for additional hyperbaric oxygen therapy (HBOT) treatments and wound healing treatments. Findings: The physician reviewer found that the records indicate that this patient’s ulcers have partially responded to standard compression therapy and there is a lack of documentation of wound hypoxia. In the current medical literature, there is insufficient evidence to support the use of HBOT for this patient’s venous ulcers. There are small case studies reporting that HBOT in combination with other modalities has resulted in improved healing of these types of ulcers. However, there is a paucity of evidence on the duration of healing or prospective trial data demonstrating superior clinical health outcomes with HBOT.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement and prospective authorization and coverage for continuation of long-term acute care hospital stay. Long-term acute care hospital level care is intended for patients who require care for more than one serious medical condition that is more medically complex than can be handled at lower levels of care such as inpatient rehabilitation facilities or skilled nursing facilities. The authors noted that an admission of 25 days or longer should generally be expected. The patient states that she has been hospitalized since February 2021. The patient was transferred back to a long-term acute care hospital, where he became significantly more medically stable and functional. By the date of denial, the patient was stable for discharge from the facility.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving skin ulcer, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY